Rights and permissions
About this article
Cite this article
Paclitaxel confers QOL benefit, lower costs in breast cancer. Pharmacoecon. Outcomes News 383, 10 (2002). https://doi.org/10.1007/BF03279704
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279704